|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation, depletion and amortization | |||||
| Amortization of deferred financing fees | |||||
| Deferred income taxes | |||||
| Stock-based compensation | |||||
| Gain on sale of assets | |||||
| Inventory impairment charges | |||||
| Other contract termination settlements | |||||
| Long-lived asset impairment charge | |||||
| Pension settlement charge | |||||
| Other | |||||
| Changes in operating assets and liabilities: | |||||
| Affiliates receivable/payable | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Other current assets | |||||
| Accounts payable | |||||
| Income taxes receivable/payable | |||||
| Other current liabilities | |||||
| Net cash provided by operating activities | |||||
| Investing Activities | |||||
| Expenditures for property, plant and equipment | |||||
| Acquisition of mineral interests | |||||
| Proceeds from the sale of assets | |||||
| Equity method investment | |||||
| Proceeds from the sale of private company equity units | |||||
| Return of equity method investment | |||||
| Other | |||||
| Net cash used for investing activities | |||||
| Financing Activities | |||||
| Net additions to revolving credit agreement | |||||
| Additions to long-term debt | |||||
| Reductions to long-term debt | |||||
| (Reductions) additions to note payable to affiliate | |||||
| Debt issuance costs | |||||
| Cash dividends paid | |||||
| Purchase of treasury shares | |||||
| Net cash (used for) provided by financing activities | |||||
| Cash and Cash Equivalents | |||||
| Total decrease for the year | |||||
| Balance at the beginning of the year | |||||
| Balance at the end of the year | |||||
Loading...